Pulse Biosciences, Inc. (PLSE)

20.51 +0.86 (+4.40%) USD  |  NASDAQ  |  Apr 16, 16:00
20.51 0.00 (0.00%) Pre-Market: 20:00
More

Pulse Biosciences Research and Development Expense (Quarterly) : 10.93M for Dec. 31, 2025

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for PLSE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 721.00M
Artivion, Inc. 9.122M
Edwards Lifesciences Corp. 267.70M
Zimmer Biomet Holdings, Inc. 118.80M
Nutriband, Inc. 0.4571M